IP Library Granted Patent US 9,434,777
Granted Patent B2
US 9,434,777 · App. 14/657,899 · Granted Sep 6, 2016

Neuregulin peptides and their use

Inventor: Mingdong Zhou (Shanghai, CN)
Assignee: Zensun (Shanghai) Science & Technology, Co., Ltd.
C07K14/4756A61K38/00A61K38/16A61K38/1883C07K14/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,434,777
App. No.
14/657,899
Granted
Sep 6, 2016
Kind
B2
Abstract

Neuregulin peptides useful, for example, in methods and compositions comprising preventing, treating or delaying various diseases or disorders are described.

Claims (13)

1. A method for treating heart failure in a subject in need thereof comprising administering intravenously or subcutaneously to the subject and effective amount of neuregulin peptide consisting of the amino acid sequence of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7 or SEQ ID NO:9.

2. The method of claim 1 , wherein the neuregulin peptide consists of the amino acid sequence of SEQ ID NO:3.

3. The method of claim 2 , wherein the neuregulin peptide is administered intravenously.

4. The method of claim 2 , wherein the neuregulin peptide is administered subcutaneously.

5. The method of claim 1 , wherein the neuregulin peptide consists of the amino acid sequence of SEQ ID NO:5 and is administered intravenously.

6. The method of claim 1 , wherein the neuregulin peptide consists of the amino acid sequence of SEQ ID NO:5 and is administered subcutaneously.

7. The method of claim 1 , wherein the neuregulin peptide consists of the amino acid sequence of SEQ ID NO:7.

8. The method of claim 7 , wherein the neuregulin peptide is administered intravenously.

9. The method of claim 7 , wherein the neuregulin peptide is administered subcutaneously.

10. The method of claim 1 , wherein the neuregulin peptide consists of the amino acid sequence of SEQ ID NO:9.

11. The method of claim 10 , wherein the neuregulin peptide is administered intravenously.

12. The method of claim 10 , wherein the neuregulin peptide is administered subcutaneously.

13. The method of any one of claim 1 , 2 , 3 , 4 , 5 - 7 , 8 - 10 , 11 or 12 , wherein the subject is human.

Assignments (1)
CHANGE OF NAME Recorded Jun 8, 2016
From: ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY, LTD.
To: ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY, CO., LTD.
Reel/Frame 038925/0398 →
Continuity (4)
Continuation 14101084 · Dec 9, 2013
Continuation 13131682
Provisional Application 61118566 · Nov 28, 2008
Related Publication 20160009774A1 · Jan 14, 2016